Ashkan Kalantary-Charvadeh

4PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersMolecular targetsCarbon capture engineering (excl. sequestration)Proteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 23, 2023
β-lapachone protects against doxorubicin-induced hepatotoxicity through modulation of NAD+ /SIRT-1/FXR/p-AMPK/NF-kB and Nrf2 signaling axis.

Ashkan Kalantary-Charvadeh, Saeed Nazari Soltan Ahmad, Somayeh Aslani

|Jun 20, 2022
Fatty acids of type 2 diabetic serum decrease the stemness properties of human adipose-derived mesenchymal stem cells.

Parisa Fayyazpour, Effat Alizadeh, Vahid Hosseini

|Apr 21, 2022
The porcupine inhibitor WNT974 provokes ectodermal lineage differentiation of human embryonic stem cells.

Ashkan Kalantary-Charvadeh, Vahid Hosseini, Amir Mehdizadeh

|May 19, 2020
Application of porcupine inhibitors in stem cell fate determination.

Ashkan Kalantary-Charvadeh, Vahid Hosseini, Amir Mehdizadeh

Pageof 1